819-P: A Novel Premix Insulin GZR101 for Diabetes Management

内科学 内分泌学 胰岛素 脱胶胰岛素 化学 血糖性 糖尿病 人血清白蛋白 脂肪生成 体内 基础(医学) 基础胰岛素 医学 2型糖尿病 生物 脂肪组织 生物化学 生物技术
作者
Wei Chen,Wancai Xing,Yining Zhang,Anshun He,JING GAO,QIMIN SHI,Fangkai Xue,YONGCHUN WANG,Jun Zhang,DONGLI YU,Cheng Cui,TIAN XIE,ZHONGRU GAN
出处
期刊:Diabetes [American Diabetes Association]
卷期号:73 (Supplement_1)
标识
DOI:10.2337/db24-819-p
摘要

Introduction: Inadequate glycemic control in patients with premix insulin regimen is often due to the short half-life and pronounced peak-to-trough ratio of basal insulin. This necessitates the development of a premix insulin containing basal insulins with an extended half-life and steady pharmacokinetic (PK) profile. Objective: This study evaluated and characterized GZR33, an ultra-long half-life basal insulin, and GZR101 which is composed by GZR33 and insulin aspart. Methods: The binding affinity of GZR33 to the human insulin receptor (hIR) was analyzed in vitro using surface plasmon resonance. IR activation was examined in CHO cells in the presence and absence of human serum albumin (HSA). Adipogenesis was measured in 3T3L1 MBX cells. Potency was tested in vivo in streptozotocin-induced T1DM rats and db/db T2DM mice, using insulin degludec (iDeg) and iDegAsp as controls. PK studies were assessed in Sprague-Dawley rats. Results: GZR33 was constructed by linking a C22 fatty diacid side chain to desB30 human insulin via a 6×OEG linker. GZR33 exhibited strong hIRA and hIRB binding (dissociation constants: 2.86E-6 M and 1.28E-6 M). It activated IRA and IRB with EC50 of 370.13 ± 94.86 nM and 477.48 ± 64.28 nM, respectively, in 0.5% HSA, and induced adipogenesis with an EC50 of 2.45 ± 0.81 nM. PK studies showed a dose-dependent increase in maximum concentration and exposure, with a T½ of 5.45 h for GZR33 (2.3 h for iDeg). In T1DM rats and T2DM mice, GZR33 outperformed iDeg in reducing HbA1c and FBG, demonstrating a potency at least three-fold higher than iDeg. Additionally, GZR101's glucose-lowering effect was proportional to the GZR33 dosage in diabetic models. Conclusion: Traditional basal insulins display a 24-hour glucose-lowering effect with noticeable peaks, leading to fluctuating blood glucose in patients. However, a basal insulin with over 3-day longevity and once-daily dosing, like GZR33, can achieve a nearly peak-less PK profile at steady-state. Consequently, GZR101 emerges as a promising once-daily premix insulin candidate. Disclosure W. Chen: None. W. Xing: None. Y. Zhang: None. A. He: None. J. Gao: None. Q. Shi: None. F. Xue: None. Y. Wang: None. J. Zhang: None. D. Yu: None. C. Cui: None. T. Xie: None. Z. Gan: None.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
qiangzhang完成签到 ,获得积分10
刚刚
2秒前
思有完成签到 ,获得积分10
2秒前
3秒前
3秒前
向前发布了新的文献求助30
6秒前
6秒前
6秒前
7秒前
7秒前
7秒前
8秒前
拼搏起眸发布了新的文献求助10
9秒前
完美世界应助干雅柏采纳,获得10
9秒前
谷粱紫槐发布了新的文献求助30
10秒前
ruanyh发布了新的文献求助10
11秒前
11秒前
12秒前
科目三应助Solaris采纳,获得30
12秒前
傲娇幼丝发布了新的文献求助10
12秒前
sophia完成签到 ,获得积分10
14秒前
研友_nxV4m8发布了新的文献求助10
15秒前
Kyros完成签到 ,获得积分10
16秒前
16秒前
16秒前
无心的沉鱼完成签到,获得积分10
17秒前
薰硝壤应助健忘瑾瑜采纳,获得30
17秒前
向前完成签到,获得积分20
17秒前
畅小畅发布了新的文献求助10
17秒前
18秒前
小写完成签到,获得积分20
19秒前
yanlingzhai完成签到 ,获得积分20
19秒前
19秒前
干雅柏发布了新的文献求助10
20秒前
张先生2365完成签到,获得积分10
21秒前
傲娇幼丝发布了新的文献求助10
21秒前
晶米发布了新的文献求助10
22秒前
小写发布了新的文献求助30
24秒前
畅小畅完成签到,获得积分20
26秒前
26秒前
高分求助中
Sustainability in Tides Chemistry 2000
The ACS Guide to Scholarly Communication 2000
Studien zur Ideengeschichte der Gesetzgebung 1000
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Threaded Harmony: A Sustainable Approach to Fashion 810
Pharmacogenomics: Applications to Patient Care, Third Edition 800
Gerard de Lairesse : an artist between stage and studio 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3076162
求助须知:如何正确求助?哪些是违规求助? 2729044
关于积分的说明 7507177
捐赠科研通 2377267
什么是DOI,文献DOI怎么找? 1260526
科研通“疑难数据库(出版商)”最低求助积分说明 611000
版权声明 597164